In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.

Researchers focus on reversing the scarring that’s common to liver diseases.

Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.

When Laurie Brunner found a lump in her breast just before Thanksgiving in 2018, it was the beginning of one of the most difficult periods of her life. Although treatment put her cancer into remission, she found herself dealing with an emotional toll that affects many survivors of early-stage breast cancer: the fear of it coming back.

Photos: Brent Stirton, Getty Images for Novartis

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Doyle describes the road to improving patient outcomes across Europe through the HARMONY Alliance.

Manju Ujjini, Head of Lead Discovery for our Global Health Biomedical Research group, discusses what’s next for his team in drug discovery